Association of MAFLD with diabetes, chronic kidney disease, and cardiovascular disease: a 4.6-year cohort study in China.
Yebei LiangHongli ChenYuexing LiuXuhong HouLi WeiYuqian BaoChunguang YangGeng ZongJiarui WuWeiping JiaPublished in: The Journal of clinical endocrinology and metabolism (2021)
The change from NAFLD to MAFLD did not affect the associations with diabetes, CKD, and CVD much. MAFLD further identified those patients of metabolically fatty liver combined with excessive alcohol consumption and HBV infection, who had increased risks of incident diabetes compared with those of non-fatty liver.
Keyphrases
- cardiovascular disease
- chronic kidney disease
- end stage renal disease
- type diabetes
- alcohol consumption
- glycemic control
- peritoneal dialysis
- ejection fraction
- newly diagnosed
- hepatitis b virus
- cardiovascular events
- cardiovascular risk factors
- fatty acid
- skeletal muscle
- patient reported outcomes
- weight gain
- climate change
- adipose tissue